Adherence and Health Effects of Video Dance in Postmenopausal Women

September 27, 2017 updated by: Stephanie Studenski, University of Pittsburgh

Phase 2 Trial of Video Dance Versus Walking in Postmenopausal Sedentary Overweight Women

This is a 6 month randomized clinical trial comparing video dance, brisk walking and delayed entry controls. The interventions have two phases; a 12 week initiation phase with substantial structure and supervision, followed by a 12 week transition phase, with reduced structure and supervision. Participants are 168 overweight or obese, sedentary postmenopausal women aged 50 to 65; 60 in each exercise arm and 48 in the wait list control group.

The following research questions will be assessed:

  1. Is exercise adherence at 6 months better with video dance games compared to brisk walking?
  2. Does video dance game exercise compared to wait list controls, induce beneficial changes in physical and mental health?
  3. Does video dance game exercise compared to brisk walking better promote balance, attention and visual spatial skills, without loss of benefit to cardiovascular fitness?
  4. Is video dance preferred to brisk walking for exercise among postmenopausal women? If so, who and why?

Study Overview

Study Type

Interventional

Enrollment (Actual)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • University of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Participants must be female
  • age 50-65
  • not currently exercising at least 20 minutes
  • three times per week
  • a BMI of 25 or higher

Exclusion Criteria:

  • Exclusions are largely related to medical safety and include history of osteoporosis, osteoporotic fractures, active cardiovascular disease, uncontrolled hypertension, weight bearing pain that would limit exercise, seizure disorder or any medical condition or medication that would limit the safety of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VideoDance
Using a commercially available product called Dance Dance Revolution (DDR) this video-game based dancing system uses a game player, force sensing pad and software. The step sequences are set to a wide range of music and become more complex and frequent as the dancer gains skill. Participants are oriented over 2 weeks. For the rest of the first 3 months, the participant attends at least one supervised session per week. Participants may use the center for additional, unsupervised sessions and/or they can take a dance system home. They also receive brief behavioral intervention sessions for safety orientation, exercise education and adherence promotion. For the following 3 months, the participant enters the transition phase in which she is encouraged to continue to exercise but no formal supervision is provided.
Other Names:
  • Konami
Active Comparator: Brisk Walking
The overall goal is to increase the duration and speed of walking, using structure and supervision for the first three months, followed by reduced support in the second three months. For the first two weeks, each participant comes to the center at least twice a week to walk.They are encouraged to gradually increase effort and duration to a target of 150 minutes per week of brisk walking.Participants are taught to use Borg's ratings of perceived exertion and self-monitored heart rate to target their level of activity. The next 10 weeks include once weekly supervised sessions and additional sessions either at the center or in preferred community settings. The recommended goal is a minimum of 150 minutes per week of exercise in sessions of at least 10 -15 minutes duration.Participants are given pedometers in order to help them monitor their progress. After 12 weeks, the participant enters a transition phase for a further 3 months.
Other: Delayed entry control
Participants who are randomized to the delayed entry non-exercise control group receive the American Heart Association pamphlet, but no direct support for exercise implementation. After they have completed six months of follow up, they are invited to select any combination of dancing and walking that they prefer and then receive support and instruction according to the protocols described above.

Participants who are randomized to the delayed entry non-exercise control group receive the American Heart Association pamphlet, but no direct support for exercise implementation. After they have completed six months of follow up, they are invited to select any combination of dancing and walking that they prefer and then receive support and instruction according to the protocols described above.

--------------------------------------------------------------------------------

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: six months after randomization
minutes per week of moderate or greater physical exercise activity assessed using accelerometers and activity diaries
six months after randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endurance
Time Frame: 3 and 6 months
timed 2 km walk
3 and 6 months
body composition
Time Frame: 6 months
Lunar Prodigy DXA scanner for lean body mass and total fat mass
6 months
vascular health
Time Frame: 6 months
blood pressure, pulse, lipid levels, fasting glucose, fasting insulin and C reactive protein
6 months
balance
Time Frame: 3 and 6 months
timed one foot stand and timed narrow walk
3 and 6 months
personality
Time Frame: baseline
NEO Personality Inventory
baseline
sleep quality
Time Frame: 3 and 6 monhts
Pittsburgh Sleep Quality Index
3 and 6 monhts
visuospatial/constructional function
Time Frame: 3 and 6 monhts
domain of the Repeatable Battery for the Assessment of Neuropsychological Status
3 and 6 monhts
attention domain
Time Frame: 3 and 6 monhts
subtests of the Repeatable Battery for the Assessment of Neuropsychological Status
3 and 6 monhts
Useful Field of View
Time Frame: 3 and 6 monhts
Useful Field of View test
3 and 6 monhts
step reaction time
Time Frame: 3 and 6 months
Step Reaction Tasks
3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie A Studenski, MD MPH, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

July 31, 2012

Study Completion (Actual)

September 30, 2012

Study Registration Dates

First Submitted

September 27, 2011

First Submitted That Met QC Criteria

September 28, 2011

First Posted (Estimate)

September 29, 2011

Study Record Updates

Last Update Posted (Actual)

October 2, 2017

Last Update Submitted That Met QC Criteria

September 27, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • PRO08080012
  • P30AG024827 (U.S. NIH Grant/Contract)
  • T32AG021885 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Menopausal

3
Subscribe